Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Lordick, F; Lorenzen, S; Stollfuss, J; Vehling-Kaiser, U; Kullmann, F; Hentrich, M; Zumschlinge, R; Dietzfelbinger, H; Thoedtmann, J; Hennig, M; Seroneit, T; Bredenkamp, R; Duyster, J; Peschel, C 
Titel:
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer. 
Abstract:
Oxaliplatin plus fluorouracil/folinic acid (5-FU/FA) every 2 weeks has shown promising activity in advanced gastric cancer. This study assessed the efficacy and safety of weekly oxaliplatin plus 5-FU/FA (FUFOX regimen) in the metastatic setting. Patients with previously untreated metastatic gastric cancer received oxaliplatin (50 mg m(-2)) plus FA (500 mg m(-2), 2-h infusion) followed by 5-FU (2000 mg m(-2), 24-h infusion) given on days 1, 8, 15 and 22 of a 5-week cycle. The primary end point of...    »
 
Zeitschriftentitel:
Br J Cancer 
Jahr:
2005 
Band / Volume:
93 
Heft / Issue:
Seitenangaben Beitrag:
190-4 
Sprache:
eng 
Print-ISSN:
0007-0920 
TUM Einrichtung:
Chirurgiesche Klinik und Poliklinik; III. Medizinische Klinik und Poliklinik; r Radiologie; r Medizinische Statistik und Epidemiologie